Related Experiment Video

Updated: Aug 7, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Lead poisoning in Minnesota Medicaid children

Erik W Zabel1, Susan Castellano

  • 1Minnesota Childhood Lead Poisoning Prevention Program, Minnesota Department of Health, USA.

Minnesota Medicine
|June 13, 2006
PubMed

Insights

Blood lead testing increased in Minnesota children, with elevated levels declining overall. However, children in public insurance programs showed higher lead rates, highlighting ongoing disparities in pediatric blood lead exposure.

Area of Science:

  • Environmental Health
  • Pediatric Public Health
  • Toxicology

Background:

  • Childhood blood lead exposure remains a significant public health concern.
  • Monitoring blood lead levels is crucial for early detection and intervention.
  • Disparities in healthcare access may influence lead testing rates and outcomes.

Purpose of the Study:

  • To analyze trends in childhood blood lead testing in Minnesota from 1999 to 2003.
  • To assess changes in the prevalence of elevated blood lead levels.
  • To examine disparities in testing and elevated blood lead levels among children in public insurance programs.

Main Methods:

  • Retrospective analysis of blood lead testing data for children younger than 6 years in Minnesota.
  • Examination of testing rates for infants and toddlers (9-30 months) enrolled in Medical Assistance and MinnesotaCare.
  • Comparison of elevated blood lead level prevalence between publicly insured and non-publicly insured children.

Main Results:

  • Blood lead testing increased significantly, from ~38,000 children in 1999 to ~61,000 in 2003.
  • The overall rate of elevated blood lead levels (≥10 µg/dL) decreased from 6% to 2.7%.
  • Children in public insurance programs had a 2-fold higher rate of elevated blood lead levels (3.4%) compared to privately insured children (1.5%) in 2003.

Conclusions:

  • While overall childhood blood lead levels declined, disparities persist for children in public insurance programs.
  • Increased blood lead testing rates are a positive trend, but targeted interventions are needed for vulnerable populations.
  • Improved follow-up retesting rates suggest enhanced management of children with elevated blood lead levels.

More Related Videos

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity08:37

Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity

Published on: October 25, 2016

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...